Jacobs Levy Equity Management’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-253,538
| Closed | -$1.88M | – | 1058 |
|
|
2020
Q3 | $1.88M | Sell |
253,538
-166,620
| -40% | -$1.24M | 0.02% | 531 |
|
|
2020
Q2 | $1.69M | Buy |
420,158
+41,748
| +11% | +$167K | 0.02% | 559 |
|
|
2020
Q1 | $961K | Sell |
378,410
-522,695
| -58% | -$1.33M | 0.01% | 627 |
|
|
2019
Q4 | $3.14M | Buy |
901,105
+771,906
| +597% | +$2.69M | 0.03% | 460 |
|
|
2019
Q3 | $598K | Buy |
129,199
+97,000
| +301% | +$449K | 0.01% | 693 |
|
|
2019
Q2 | $397K | Sell |
32,199
-249,996
| -89% | -$3.08M | 0.01% | 776 |
|
|
2019
Q1 | $3.75M | Buy |
282,195
+52,100
| +23% | +$692K | 0.05% | 384 |
|
|
2018
Q4 | $1.98M | Sell |
230,095
-13,852
| -6% | -$119K | 0.03% | 463 |
|
|
2018
Q3 | $1.83M | Sell |
243,947
-11,345
| -4% | -$85K | 0.03% | 539 |
|
|
2018
Q2 | $1.52M | Buy |
255,292
+9,791
| +4% | +$58.4K | 0.02% | 558 |
|
|
2018
Q1 | $1.43M | Buy |
245,501
+4,300
| +2% | +$25.1K | 0.02% | 550 |
|
|
2017
Q4 | $1.42M | Buy |
241,201
+3,100
| +1% | +$18.3K | 0.03% | 541 |
|
|
2017
Q3 | $1.2M | Buy |
238,101
+36,850
| +18% | +$186K | 0.02% | 545 |
|
|
2017
Q2 | $813K | Buy |
201,251
+24,700
| +14% | +$99.8K | 0.02% | 603 |
|
|
2017
Q1 | $1.01M | Buy |
176,551
+120,251
| +214% | +$685K | 0.02% | 554 |
|
|
2016
Q4 | $410K | Buy |
56,300
+10,300
| +22% | +$75K | 0.01% | 717 |
|
|
2016
Q3 | $368K | Hold |
46,000
| – | – | 0.01% | 766 |
|
|
2016
Q2 | $415K | Hold |
46,000
| – | – | 0.01% | 804 |
|
|
2016
Q1 | $371K | Buy |
+46,000
| New | +$371K | 0.01% | 812 |
|